Oppenheimer Maintains an 'Outperform' on Life Technologies (LIFE); Upcoming Catalyst: Ion World 2012
Tweet
Share
E-mailGet Alerts LIFE Hot Sheet
Price: $34.02 -2.24%
Rating Summary:
15 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
15 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer maintains an 'Outperform' on Life Technologies (NASDAQ: LIFE) price target of $58.00.
Analyst, David Ferreiro, said, "Despite accounting for only ~5% of total revenue, LIFE’s next generation sequencing (NGS) business has become a significant investor focus, primarily for its potential as the next major growth driver. The Ion Proton launch has been greatly anticipated due to its promise of the elusive $1000 genome. Early demand has been significant as management has indicated booking more than 100 system orders. Coincident with the launch, LIFE will be hosting Ion World 2012 in San Francisco on September 13-14. We expect the symposium to serve as a catalyst for shares as the program will detail both the research and clinical potential of the platform. We believe our 2013-16 Proton estimates to be conservative, and note that a launch trajectory that mirrors either the HiSeq (Nasdaq: ILMN) or PGM (LIFE) could add up to $0.06 and $0.39 to our EPS estimates in 2013 and 2014, respectively."
For an analyst ratings summary and ratings history on Life Technologies click here. For more ratings news on Life Technologies click here.
Shares of Life Technologies closed at $47.71 yesterday.
Analyst, David Ferreiro, said, "Despite accounting for only ~5% of total revenue, LIFE’s next generation sequencing (NGS) business has become a significant investor focus, primarily for its potential as the next major growth driver. The Ion Proton launch has been greatly anticipated due to its promise of the elusive $1000 genome. Early demand has been significant as management has indicated booking more than 100 system orders. Coincident with the launch, LIFE will be hosting Ion World 2012 in San Francisco on September 13-14. We expect the symposium to serve as a catalyst for shares as the program will detail both the research and clinical potential of the platform. We believe our 2013-16 Proton estimates to be conservative, and note that a launch trajectory that mirrors either the HiSeq (Nasdaq: ILMN) or PGM (LIFE) could add up to $0.06 and $0.39 to our EPS estimates in 2013 and 2014, respectively."
For an analyst ratings summary and ratings history on Life Technologies click here. For more ratings news on Life Technologies click here.
Shares of Life Technologies closed at $47.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ethos Signs Erin Andrews as Its Next Sports Partner in Growing Campaign to Make Life Insurance Accessible for Every Family
- Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
- Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
